GAYRO PILLS 500MG

Giro)

Active ingredient and dosage form

Guyro - coated tablets:

1 pill contains 500 mg ornidazole; 3, 6, 9, 10, 15, 20 or 30 pieces per pack.

Mechanism of action

Gairo is an antiprotozoal agent derived from 5-nitroimidazole. It is believed that the mechanism of action is associated with a violation of the structure of the DNA of sensitive microorganisms. It is active against Trichomonas vaginalis, Giardia lamblia, Entamoeba histolytica, as well as against some anaerobic bacteria (including Bacteroides spp., Clostridium spp., Fusobacterium and anaerobic cocci).

Trichomoniasis, amebiasis (intestinal and non-intestinal forms, including amoebic dysentery and amebic abscess of the liver), giardiasis, prevention of postoperative complications (especially during operations on the colon or in gynecology).

Contraindications

CNS diseases, acute neurological diseases, I trimester of pregnancy, lactation period, hypersensitivity to ornidazole.

Pregnancy and Breastfeeding

In pregnancy, the use of Gayro is possible only by absolute indications, if the expected benefit to the mother outweighs the potential risk to the fetus.

Adverse reactions

On the part of the digestive system: possible - nausea, heartburn, dizziness, drowsiness, skin rash.

On the part of the nervous system: possible - headache, dizziness, impaired consciousness, tremor, muscle rigidity, impaired motor coordination, convulsions, sensory or mixed peripheral neuropathy, nausea, vomiting, diarrhea.

Dosage and administration

For oral administration, depending on the indications, treatment regimen and the patient's body weight, a single dose of Gayro for adults varies from 500 mg to 2 g; for children weighing up to 35 kg, the daily dose is 20-40 mg / kg. Frequency of reception and duration of use are set individually.

In the treatment of trichomoniasis should be the simultaneous treatment of both partners.

Storage conditions

Store the preparation in a dry, dark place at a temperature not exceeding 25 ° C. Shelf life 3 years.